Risk factors of intracranial hemorrhage with 125I seeds for the treatment of brain tumors / 中华内科杂志
Chinese Journal of Internal Medicine
;
(12): 298-303, 2022.
Artículo
en Chino
| WPRIM
| ID: wpr-933451
ABSTRACT
Objective:
To analyze the risk factors of intracranial hemorrhage after implanting 125-iodine seeds for brain tumors.Methods:
A total of 234 patients with intracranial tumors receiving treatment of 125-iodine seeds from March, 2013 to November, 2020 were retrospectively analyzed. Patients were divided into bleeding group and non-bleeding group according to whether postoperative intracranial hemorrhage was reported. Univariate and multivariate analysis was performed by logistic regression to determine the independent risk factors of intracranial hemorrhage.Result:
A total of 22 cases (9.4%) reported postoperative intracranial hemorrhage in 234 patients treated with 125-iodine seeds. Univariate analysis showed that the type of tumor and the history of anti-angiogenic drug within one month were possible risk factors ( P<0.1). Multivariate logistic regression analysis showed that anti-angiogenic drug within one month was the independent risk factor for intracranial hemorrhage ( P<0.05).Conclusions:
The application of anti-angiogenic drugs within one month is the independent risk factor of intracranial hemorrhage with 125-iodine seeds for the treatment of brain tumors.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Estudio de etiología
/
Factores de riesgo
Idioma:
Chino
Revista:
Chinese Journal of Internal Medicine
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS